Publikace UTB
Repozitář publikační činnosti UTB

What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study en
dc.contributor.author Šálek, Tomáš
dc.contributor.author Musil, Pavel
dc.contributor.author Zlatníková, Irena
dc.relation.ispartof Biochemia Medica
dc.identifier.issn 1330-0962 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2025
utb.relation.volume 35
utb.relation.issue 3
dc.citation.spage 31001
dc.type article
dc.language.iso en
dc.identifier.doi 10.11613/BM.2025.031001
dc.relation.uri https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001/fullArticle
dc.relation.uri https://www.biochemia-medica.com/assets/images/upload/xml_tif/bm-35-3-031001.pdf
dc.subject nephrolithiasis en
dc.subject specimen preservation en
dc.subject uric acid en
dc.subject urine en
dc.subject urine specimen collection en
dc.subject citrate potassium en
dc.subject potassium citrate en
dc.subject case report en
dc.subject drug therapy en
dc.subject human en
dc.subject male en
dc.subject middle aged en
dc.subject pH en
dc.subject humans en
dc.subject hydrogen-ion concentration en
dc.subject kidney calculi en
dc.subject malepotassium citrate en
dc.description.abstract This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making. This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine en
utb.faculty Faculty of Humanities
dc.identifier.uri http://hdl.handle.net/10563/1012525
utb.identifier.scopus 2-s2.0-105013687779
utb.identifier.pubmed 40822842
utb.source j-scopus
dc.date.accessioned 2025-10-16T07:25:46Z
dc.date.available 2025-10-16T07:25:46Z
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.rights.access openAccess
utb.ou Department of Health Care Sciences
utb.contributor.internalauthor Šálek, Tomáš
utb.fulltext.sponsorship -
utb.scopus.affiliation Tomas Bata Hospital in Zlín, Zlin, Czech Republic; Tomas Bata University in Zlin, Zlin, Czech Republic
utb.fulltext.projects -
Find Full text

Soubory tohoto záznamu

Zobrazit minimální záznam

Attribution 4.0 International Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Attribution 4.0 International